If You Want to Feel Energetic, Prevent Disease, and Lose Weight, Try the “Eat to Live” Lifestyle – POPSUGAR

Last Updated on August 1, 2020 by

While looking for vegan recipe inspiration on Instagram, I stumbled on the hashtag #nutritarian, an eating lifestyle developed Joel Furman, MD, who wrote the book Eat to Live. After scrolling through gorgeously colored plant-based recipes and reading a little bit about the science behind a nutritarian diet, I immediately ordered the book so I could learn more.

The book begins with an explanation of why the standard American diet, full of processed, high-calorie, nutrient-deficient food, may lead to health problems, such as high blood pressure, heart disease, and cancer, as well as early death. He touches on the health risks of eating too much meat and dairy, the dangers of yo-yo dieting, and Dr. Furman’s simple solution — to eat high-nutrient, low-calorie foods.

A nutritarian diet focuses on nutrient-dense foods that prevent disease instead of causing it. It’s comprised of a plant-based diet that includes tons of greens, other veggies, fruit, legumes, and a limited amount of whole grains, nuts, and seeds. You also avoid processed foods like refined flours and packaged foods, sugar, oil, and salt. This way of eating is meant to help prevent disease, give you energy, help you naturally lose weight (and easily sustain it), and help lengthen your life.

If you’re new to the nutritarian lifestyle and ready to improve your health through diet, in the book Dr. Furman recommends starting out with the Six-Week Plan outlined below. He says that if you stick to this plan strictly for six weeks, your body will undergo a remarkable transformation as you notice changes in your physical and emotional well-being — you’ll feel better than you have in years. Your digestion will improve, you’ll lose cravings for unhealthy foods, and he says in the book, “you will be thrilled with how easily your weight drops.”

Six-Week Plan Explanation

There are many foods restricted on the Six-Week Plan, including meat and dairy, for the health risks mentioned above. There is also no snacking in between meals because you’re supposed to eat a huge veggie-packed meal so you’re so satisfied until your next meal. This also gives your digestive system a break, since many of us are used to snacking all day.

Oils aren’t permitted, even coconut or olive oil, as Dr. Furman says they add extra calories without the fiber to fill you up. He recommends getting your healthy fats through avocados, nuts, and seeds instead, since these offer protein and fiber as well. You are also to avoid added salt, since excess salt is linked to stomach cancer, high blood pressure, and osteoporosis. Foods naturally contain the sodium your body needs, and your taste buds will soon get used to not having extra salt.

The Eat to Live Six-Week Plan


Eat as much as you want:

  • All raw vegetables (goal: 1 pound)
  • Cooked green and nongreen nutrient-rich vegetables: eggplant, mushrooms, peppers, onions, tomatoes, carrots, zucchini, cucumbers, celery, cauliflower (goal: 1 pound daily)
  • Beans, legumes, bean sprouts, and tofu (goal: 1 cup)
  • Fresh fruit (at least 4 daily)


  • Cooked starchy vegetables or whole grains: butternut and acorn squash, corn, white and sweet potatoes, turnips, parsnips, rice, bread, cereal, oatmeal (no more than one serving or 1 cup)
  • Raw nuts and seeds (1 ounce max per day)
  • Avocado (2 ounces max per day)
  • Dried fruit (2 tablespoons max per day)
  • Ground flaxseeds (1 tablespoon max per day)


  • Dairy
  • Animal products
  • Between-meal snacks
  • Fruit juice
  • Oils
  • Added salt

As stated in the book, here are Dr. Furman’s 10 easy tips for living with the Six-Week Plan:

  1. Remember, the salad is the main dish: eat it first at lunch and dinner. You can eat more than a pound if you want, but don’t worry if you’re too full and can’t eat the whole pound.
  2. Eat as much fruit as you want but at least four fresh fruits daily. Enjoy fresh fruit as dessert, or blend frozen fruit and make nice cream.
  3. Variety is the spice of life, particularly when it comes to greens. Explore all the different greens, raw veggies, cooked veggies, and use frozen veggies when you’re in a rush.
  4. Beware of the starchy vegetable. Limit high-starch grains and vegetables to one cup a day, and fill up on the raw and non-starchy veggies first. Refined grains such as bread and pasta should be even more restricted than the vegetable-based starches.
  5. Eat beans or legumes every day. You can have more than one cup if you choose, adding beans to smoothies, salads, and soups.
  6. Eliminate animal and dairy products. If this is too hard, eat lean fish once or twice a week and eggs once a week. No dairy products are permitted on the Six-Week Plan.
  7. Have a tablespoon of ground flaxseeds every day. This will offer you omega-3 fats that may protect against heart disease, reduce inflammation, and prevent age-related mental decline such as dementia and Alzheimer’s Disease. Add to smoothies, salad, oatmeal, or nice cream.
  8. Consume nuts and seeds in limited amounts, not more than one ounce per day. Pecans, walnuts, sunflower seeds, and other nuts and seeds offer disease protection, but they are high in calories and fat.
  9. Eat lots of mushrooms all the time. They make a great chewy replacement for meat and contain a variety of powerful phytochemicals that may decrease risk of chronic disease, especially cancer.
  10. Keep it simple. If you’re not sure what to eat, enjoy fruit for breakfast, a lunchtime salad with beans on top and more fruit, and for dinner, have a salad with two cooked veggies. Finish off with fruit or frozen fruit for dessert.

After completing the Six-Week Plan, you move on to the Life Plan, which offers more choices. Basically, you follow a nutritarian diet 90 percent of the time, which leaves 10 percent left or about 150 calories of low-nutrient foods such as chocolate, cheese, or a bagel. If you want to reintroduce meat and dairy back into your diet, he recommends 12 or fewer ounces per week. This means that on the Life Plan, you’re allowed to eat almost any kind of food, even a small cookie or candy bar, as long as the rest of the food you eat that day is plant-based and nutrient-dense.

The 10 Healthy Foods You Should Be Eating On The Keto Diet, From a Nutritionist – Sporteluxe

Last Updated on August 1, 2020 by

The Ketogenic Diet (or Keto diet as it’s now known), is a diet very low in carbohydrates, high in fat, and low to moderate in protein. The reduction in carbohydrate intake puts your body in a metabolic state called ketosis where your body uses ketones as an alternative source of energy instead of glucose.

When we eat very few carbs or very few calories, ketones are produced by the liver from fat. The ketones are then used as fuel throughout the body, especially for the brain, which can’t utilize fat directly and can only run on glucose or ketones. This is the reason why the ketogenic diet has been used to successfully treat childhood epilepsy since the 1920s.

To summarise, when you are on a keto diet, your body’s main fuel supply is fat instead of glucose. That’s what being ‘fat adapted’ means.

One of the best ways to induce ketosis is fasting or creating a ‘ketogenic ratio’ of 4-parts fat to 1-part protein and carbohydrate, which equates to around 80% of calories in the diet from fat. The protein recommendation is 1.2-3g of protein per each kilogram of body weight per day and the rest of your daily calorie allowance is from carbohydrates.

At 60kg and 2000 kcal per day, the exact macros would be

  • Fat: 1600 kcal (178g)
  • Protein: 288 kcal (72g)
  • Carbohydrate: 112 kcal (28g)

This can be tricky to maintain and you can actually achieve great results by trying a modified ketogenic diet with 60-75% of calories from fat if you use MCTs (Medium Chain Triglycerides). That way you can have more carbohydrates and protein.

What to eat on Ketogenic Diet and how to calculate Net Carbs?

The most important thing in reaching the state of ketosis (and staying in it) is not having too many carbs. You’ll likely need to keep your carb intake under 50 grams of net carbs per day, ideally below 20 grams. If you give your body carbs, your insulin will shoot up and your body will use blood glucose instead of fat.

In Australia, it’s pretty easy to simply follow the Carbohydrates figure shown in the nutrition information panel. However, when checking the carb content for the US / Canadian labels, you should subtract Dietary Fibre from Carbohydrates to get Net Carbs (Total Carbs minus Fibre = Net Carbs). Fiber is a type of carbohydrate that your body can’t digest which means it does not affect our blood sugar levels so it’s fine to work off Net Carbs.

The second important thing is about choosing healthy foods. Sure, you can consume lots of fat and little carbs by eating sausages, bacon, and cream but this kind of diet will not only rob you of essential nutrients necessary for your health and performance, but it’s also inflammatory and carcinogenic.

Top ten healthy foods to eat on a Keto Diet

1. Low carb vegetables:

Top keto foods
Photo by Louis Hansel @shotsoflouis on Unsplash

you can use them to replace your starchy faves by making cauliflower rice, zucchini pasta, spinach bread. Vegetables must remain on your menu no matter what diet you are on. They are a great source of vitamins, minerals, and fiber. You need them for a healthy gut and colon and for your daily vitamin and mineral intake.

2. Seafood:

Top keto foods
Photo by Christine Siracusa on Unsplash

Have a good variety and lots of fatty fish such as salmon, sardines, and mackerel. Go for wild-caught.

3. Meat and poultry:

Top keto foods
Photo by Eduardo Roda Lopes on Unsplash

Especially organ meat. Just 100g of organic liver contains 50% of your daily vitamin and mineral requirement. Always choose grass-fed, and organic if available.

4. Avocados:

Image: Alina Karpenko via Unsplash

They have a very low net carb count and very high potassium and fat content.

5. Eggs:

Photo by Krisztina Papp on Unsplash

Eggs are the perfect keto food as they have less than 1g carbs and 6g of protein. The yolks are packed with nutrients including antioxidants

6. Coconut and olive oil:

Keto foods
Image: Cobram Estate

Use olive oil for cold dishes and coconut oil for cooking and baking. Coconut contains MCTs, which are converted to ketones more rapidly than other fats.

7. Nuts and seeds:

Photo by Jenn Kosar on Unsplash

They are high in fat and fiber and low in carbs. You can use them for a snack or give your salad crunch. The best is that you can use any nut meal (groundnuts) to replace flour in baking. Zucchini bread made from zucchini, almond meal, eggs, and olive oil is totally keto and tastes delicious. So you don’t have to give up your smashed avo. We also base our keto-friendly Chief Collagen Bars on nuts if you’re looking for an on the go snack.

8. Berries:

Keto foods
Photo by Alex Block on Unsplash

They are low in carbs and high in fiber and antioxidants. The perfect keto sweet treat. Especially when you put them into your coconut yogurt or blend with coconut cream. Yum!

9. Konjac noodles:

Konjac noodles
Photo by Markus Winkler on Unsplash

These noodles have almost no calories and virtually no carbs, making them perfect for the keto diet. How about chicken bone broth with konjac noodles?

9. Dark chocolate and cocoa powder:

Dark chocolate
Photo by Charisse Kenion on Unsplash

It has to be high in cocoa to be suitable for keto. 100% cocoa is the best but you can start with 80% to get used to it. It has lots of good stuff in it such as antioxidants. It’s only healthy in small amounts as an occasional treat.

See also

how to Stay Positive During the Coronavirus Crisis

Veronika Larisova is a Nutritionist, Exercise Physiologist, Fitgenes practitioner, and Educator who has worked with a wide range of clientele ranging from Olympic athletes to weekend warriors. She is also the Co-Founder of Chief Nutrition.

Small children carry high amounts of virus; safely opening colleges will be a challenge – Reuters

Last Updated on August 1, 2020 by

FILE PHOTO: A teacher screens students as schools begin to reopen after the coronavirus disease (COVID-19) lockdown in Langa township in Cape Town, South Africa June 8, 2020. REUTERS/Mike Hutchings/File Photo

(Reuters) – The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Open here in an external browser for a Reuters graphic on vaccines and treatments in development.

Smallest children carry highest viral loads

While COVID-19 viral loads have been shown to be similar in children and adults, a new study finds the youngest children – those under age five – carry particularly large amounts of the coronavirus in the nose and throat. Researchers in Chicago tested swab samples from 145 individuals ages one month to 65 years with mild to moderate COVID-19. Their analysis suggests that in the youngest children, the viral load in the upper respiratory tract was 10-fold to 100-fold greater than in adults. The viral load test results did not distinguish between infectious virus particles and non-infectious genetic material from the virus, so it is not clear whether the younger children are more likely to spread the virus. However, the researchers said on Thursday in JAMA Pediatrics, studies suggest that in young children, levels of the non-infectious genetic material may be linked with levels of active virus, and so these youngsters “can potentially be important drivers of SARS-CoV-2 spread in the general population.” (reut.rs/3gkLsam; bit.ly/2PcRttE)

Safe college reopening is possible but will be challenging

If among 5,000 residential college students there are 10 with undetected coronavirus infection, all 5,000 would need to be tested for the virus every two days in order to control COVID-19 outbreaks on campus at a reasonable cost, researchers say. Their computer models assumed that students with positive tests or with COVID-19 symptoms would be moved to an isolation dormitory. “Obtaining an adequate supply of testing equipment will be a challenge,” the researchers acknowledge. “On a college campus with 5,000 enrollees, screening students every two days will require more than 195,000 test kits” during an abbreviated semester, they estimated. Reopening college campuses imposes risks that extend beyond students to the faculty, the administrative and facilities staff, and the surrounding community, the researchers note in a report on Friday in JAMA Network Open. “We believe that there is a safe way for students to return to college in fall 2020,” they said. In this study, screening every two days using a rapid, inexpensive, and even poorly sensitive test, coupled with strict interventions could yield a modest number of containable infections and be cost-effective, the researchers added. But logistically, financially, and behaviorally, this “may be beyond the reach of many university administrators,” they conclude. (bit.ly/3jXBzS3)

Antibody drug, J&J vaccine candidate may hold promise

A small study of an antibody drug in nursing home patients in Cuba and one of an experimental Johnson & Johnson vaccine in primates each added to hope that additional effective treatments for COVID-19 are on the horizon. The antibody drug, itolizumab, given along with standard therapy, helped reduce inflammation and lowered the risk of intensive care admission and death among 19 moderately ill nursing home residents. All had chronic conditions such as hypertension, dementia, heart disease, diabetes and lung diseases, increasing their risk for severe COVID-19. When researchers compared them to similar elderly COVID-19 patients who did not receive itolizumab, they estimated that treating three such patients with the drug could prevent one intensive care unit (ICU) admission and one death. The study, which did not directly compare itolizumab to a placebo or other treatments, has not yet been peer-reviewed. J&J, meanwhile, has launched U.S. human safety trials for its COVID-19 vaccine candidate after data published on Thursday in Nature showed that monkeys treated with the vaccine were strongly protected with a single dose. The drugmaker said it has started early human trials of the vaccine in the United States and Belgium and would test it in more than 1,000 healthy adults aged 18 to 55 years, as well as adults aged 65 years and older. (reut.rs/2XgPuZD; reut.rs/319SWX6; go.nature.com/2Xez04o; bit.ly/2DkbOus)

Reporting by Nancy Lapid, Vishwadha Chander and Julie Steenhuysen; Editing by Bill Berkrot

UN health agency: Must learn to live with COVID-19 – Anadolu Agency

Last Updated on August 1, 2020 by


The World Health Organization noted Friday that the world must learn to live with the coronavirus and fight it with the tools it has, despite efforts to develop a vaccine going on at record speed.

WHO chief Tedros Adhanom Ghebreyesus made the remarks at a high-level committee meeting six months after it declared COVID-19 a public health emergency.

“It’s sobering to think that six months ago when you (the International Health Regulations Emergency Committee) recommended I declare a public health emergency of international concern, there were less than 100 cases and no deaths outside China,” Tedros said.

He said that since the onset of the virus, many scientific questions had been resolved, and many remain unanswered.

The emergency committee is always cautious in its pronouncements and on Friday it reevaluated the COVID-19 emergency status.

Before COVID-19, WHO declared a public health emergency for swine flu, polio, Zika, and Ebola.

Tedros said: “Early results from serology studies are painting a consistent picture: most of the world’s people remain susceptible to this virus, even in areas that have experienced severe outbreaks.

“Many countries that believed they were past the worst are now grappling with new outbreaks.”

He said some countries, less affected in the earliest weeks, are now seeing escalating numbers of cases and deaths, while some that had large outbreaks have brought them under control.

“Although vaccine development is happening at record speed, we must learn to live with this virus, and we must fight it with the tools we have,” said Tedros.

Tedros said a complete understanding of the epidemiology and global risk posed by this novel virus requires systematic serologic testing, which reveals critical information.

“Serologic testing detects antibodies in the blood that indicate if a person has already been infected,” said the WHO chief.

“It tells us how frequently infection occurs among different populations, how many people have had mild or asymptomatic infection, and how many people have been infected but may not have been identified by routine disease surveillance.”

Tedros said serologic testing might reveal what proportion of the population could be immune in the future.

“This will allow local, national, and international decision-makers to respond collectively, and more effectively, to the pandemic,” he said.

Anadolu Agency website contains only a portion of the news stories offered to subscribers in the AA News Broadcasting System (HAS), and in summarized form. Please contact us for subscription options.

Memory loss reversed or abated in those with cognitive decline – Science Daily

Last Updated on August 1, 2020 by

Latest research from Affirmativ Health succeeds in treating cognitive decline using personalized, precision medicine.

Affirmativ Health sought to determine whether a comprehensive and personalized program, designed to mitigate risk factors of Alzheimer’s disease could improve cognitive and metabolic function in individuals experiencing cognitive decline. Findings provided evidence that this approach can improve risk factor scores and stabilize cognitive function.

July 31, 2020/Sonoma, CA Cognitive decline is a major concern of the aging population. Already, Alzheimer’s disease affects approximately 5.4 million Americans and 30 million people globally. Without effective prevention and treatment, the prospects for the future are bleak. By 2050, it is estimated that 160 million people globally will have the disease, including 13 million Americans, leading to potential bankruptcy of the Medicare system. Unlike several other chronic illnesses, Alzheimer’s disease is on the rise — recent estimates suggest that Alzheimer’s disease has become the third leading cause of death in the United States behind cardiovascular disease and cancer. Since its first description over 100 years ago, Alzheimer’s disease has been without effective treatment. While researchers continue to seek out a cure, it is becoming clear that there are effective treatment options. More and more research supports the conclusion that Alzheimer’s disease is not a disease of only Beta Amyloid plaques and Tao tangles but a complex and systemic disease. In this study of patients with varying levels of cognitive decline, it is demonstrated how a precision and personalized approach results in either stabilization or improvement in memory.

Interventions to stop the progression of Alzheimer’s disease have been marginally successful at best. This study uses a more comprehensive, personalized approach addressing each participant’s unique risk factors. “The findings, published in the Journal of Alzheimer’s Disease Reports (Journal of Alzheimer’s Disease Reports 4(1)), are encouraging and indicate that a more extensive clinical study is warranted,” said Brian Kennedy, PhD, Director of The Centre for Healthy Aging, National University Health System, Singapore and Chief Scientific Officer, Affirmativ Health.

The Affirmativ Health scientific team, after thorough review of published research, has developed a comprehensive approach to addressing scientifically supported risk factors that have been rigorously defined as interventions to promote prevention, increased resiliency, and stabilization of brain function in the realm of AD and dementia. Utilizing cutting edge technology in concert with in-person coaching and consultation, we are demonstrating that a multi-modal and personalized approach promotes an improved resiliency and restoration of optimal brain function. The personalized therapeutic program includes genetics, an extensive blood panel, medical history and lifestyle data to evaluate relevant metabolic risk factors and nutrient levels associated with cognitive health. “Target laboratory levels differ from standard laboratory ranges as the goal is to reach optimized levels for cognitive health,” Ginger Schechter, MD, Chief Medical Officer, Affirmativ Health

The study approach considers more than 35 factors known to contribute to cognitive decline. Results demonstrate that certain of those factors are more affected than others again demonstrating the need for a more precise treatment plan. “This study supports the need for an approach that focuses on a one-size fits one, not a one-size fits all, approach that comprehensively assesses all involved risk factors affecting memory loss,” Denise M Kalos, CEO Affirmativ Health

In conjunction with the publication of this vital study, and to expose alternative treatment options for Alzheimer’s disease and cognitive decline, the team at Affirmativ Health has written a book, Outsmart your Brain — an Insider’s Guide to Life-Long Memory. “Memory is not something that should diminish with age; you are never too young to start developing healthy habits that can ultimately impact your cognition,” Outsmart Your Brain. This book leverages the foundation of Affirmativ Health’s research to deliver a tips and tools guide for the maintenance of good cognitive health. “Far too few people understand how critical lifestyle and dietary choices are for brain function. ‘Outsmart Your Brain’ is an important tool to get this information into the hands of those who should know it, everyone!, in easy-to-understand language,” Ryan R. Fortna, MD, PhD, Chief Medical/Scientific Officer, ADx Healthcare.

Story Source:

Materials provided by IOS Press. Note: Content may be edited for style and length.

Antiabortion ethicists and scientists dominate Trumps fetal tissue review board – Science Magazine

Last Updated on August 1, 2020 by



Health and Human Services Secretary Alex Azar (right) is carrying out President Donald Trumps fetal tissue policy.

REUTERS/Jonathan Ernst

Last summer, the Trump administration clamped down on federally funded fetal tissue research by requiring that such projects go through an ethics review by a new advisory board. Research advocates were eager to learn who Health and Human Services (HHS) Secretary Alex Azar would appoint to the board and to see its ideological makeup. Today they got their first look as it gathered online for a one-time meeting run by the National Institutes of Health (NIH).

Although the 1-hour public portion of the meeting was perfunctory—limited to introductions and public comments—it offered a glimpse of the opposition that may greet proposals to work with fetal tissue donated after elective abortions. At least 10 of the 15 members of the NIH Human Fetal Tissue Research Ethics Advisory Board oppose abortion, and several have publicly stated positions against the funding of fetal tissue research.

“The board is stacked with people who are known to oppose use of tissue from induced abortions, regardless of the scientific necessity and regardless of the fact that using such tissue does not in any way affect whether an abortion will take place,” says R. Alta Charo, a lawyer and bioethicist at the University of Wisconsin, Madison. Charo concedes that the board includes “real scientists who understand the research importance of this tissue.” But because it does not need to reach unanimity in order to reject a proposal, their presence “will not stand in the way of a majority dismissing it out of hand.”

But Mallory Quigley, vice president of communications for the Susan B. Anthony List, which opposes abortion, says previous expert panels examining “similar topics … have leaned heavily toward people in favor of abortion on demand and research that destroys embryos. We are pleased and encouraged to see this board is more properly balanced.”

Scientists use human fetal tissue for research on diseases from HIV to Alzheimer’s. More recently, at least one scientist has been kept from studying the new coronavirus by his lack of access to the tissue, his colleagues told The Washington Post. A 2018 NIH workshop attended by HHS leaders concluded that human fetal tissue remains the “gold standard” for certain studies.

NIH officials and board members did not reveal the number of proposals being reviewed by the board in the closed session of today’s meeting. But NIH Principal Deputy Director Lawrence Tabak told panelists that it includes proposals responding to a $20 million NIH program funding research on alternatives to fetal tissue. NIH Director Francis Collins has previously said such work cannot be done without using fetal tissue as a comparator.

Tabak noted that the proposals being reviewed today have already been recommended for funding after two stages of scientific review. The board’s task, he said, was to “address whether the [HHS] Secretary should or should not withhold funds for a proposed project because of ethical considerations.” The review will include the consent process used to obtain the tissue donation from a woman having an abortion. The board will disclose its decisions in a report to be submitted to Azar and to Congress by 18 August.

During a brief public comment period this morning, two scientists and one bioethicist, Charo, defended the use of fetal tissue, noting its use in research on AIDS, cancer, blindness, neonatal treatments, and vaccines. “No tissue culture research can substitute,” said Stanford University stem cell researcher Irving Weissman.

Two researchers expressed opposition to the use of fetal tissue. Such work is unethical if “even in a small part contributory to motivating elective abortions,” asserted James Sherley, an associate scholar at the antiabortion Charlotte Lozier Institute and director of the adult stem cell company Asymmetrex. (Sherley was one of two scientists who sued NIH in 2010 to try to stop the agency from funding human embryonic stem cell research.)

The board’s chair, Paige Comstock Cunningham, an attorney, ethicist, and opponent of fetal tissue research, noted her “appreciation to Secretary Azar and the leadership” for setting up “what I believe to be the first time there has been this kind of independent ethics advisory board reviewing these proposals.”

The law governing the new board requires it to include at least one attorney, ethicist, practicing physician, and theologian as well as biomedical or behavioral researchers. Here’s a breakdown of its 15 members, who were selected from among 105 nominations, according to an NIH spokesperson:

Paige Comstock Cunningham, the board’s chair, is a lawyer with a Ph.D. in educational studies from an evangelical divinity school. She is interim president of Taylor University, an evangelical Christian university in Upland, Indiana, and executive director of the Trinity International University Center for Bioethics & Human Dignity. She is the former president of an antiabortion organization, Americans United for Life. Cunningham has testified before Congress in opposition to fetal tissue research, and in opposition to the Supreme Court nomination of Ruth Bader Ginsburg, in part because of her support for abortion rights.

Greg Burke, an internist in private practice in Danville, Pennsylvania, is a co-chair of the Catholic Medical Association’s (CMA’s) ethics committee. He also writes regularly on bioethical issues and has argued that contraception leads to “lessened human dignity” but is “warped into an almost ubiquitous argument for so-called ‘women’s rights.’”

Maureen Condic is one of three committee members affiliated with the Charlotte Lozier Institute and a developmental biologist at the University of Utah, where she attempts to coax cells from amniotic fluid to become heart cells that could treat congenital heart defects. She has served since 2018 on the Trump administration’s National Science Board, advising the National Science Foundation. ScienceInsider profiled her here.

G. Kevin Donovan is a pediatrician who directs a center for clinical bioethics at Georgetown University. His 2016 testimony before a House committee examining bioethics and fetal tissue included this statement: “Moral arguments exist that support our natural abhorrence at the trafficking of human fetal parts. Surely we can, and surely we must, find a better way.”

Ashley Fernandes, a pediatrician and associate director of the center for bioethics at the Ohio State University College of Medicine and Nationwide Children’s Hospital, also holds a doctorate in philosophy and is a member of CMA. With others in that group, he wrote (PDF) to the Ohio state legislature last year, urging it to pass a bill that would ban abortion after a fetal heartbeat becomes detectable about 6 weeks into pregnancy.

Lawrence Goldstein, a neuroscientist at the University of California, San Diego, has used human fetal tissue in his research on Alzheimer’s disease and has been an outspoken advocate of its use. Last year, when the Trump administration announced the new restrictions on the research, he told ScienceInsider: “I think it’s a terrible policy ultimately. If you think about it, fetal tissue will be incinerated instead of using it for valuable research. What’s the sense in that?”

Ashwini Lakshmanan, a neonatologist at the Keck School of Medicine at the University of Southern California, also studies discrepancies in health care delivery around and soon after the time of birth.

Thomas Meade, an inorganic chemist and molecular imaging expert at Northwestern University, studies the development of probes for magnetic resonance and optical imaging.

C. Ben Mitchell is a professor of moral philosophy at Union University, a Christian university in Jackson, Tennessee. Mitchell has a Ph.D. in philosophy with a concentration in medical ethics from the University of Tennessee. He has worked, variously, with or for the Southern Baptist Theological Seminary, Johns Hopkins University’s Genetics and Public Policy Center, and the Council for Biotechnology Policy. Widely quoted in the media, he has testified before Congress, where he vehemently opposed an Obama administration requirement that health insurance plans, including those offered by employers that oppose birth control, provide women with free contraception. 

Susan Kay Murphy, an epigeneticist who studies gynecological malignancies at the Duke University Medical Center, is currently focused on the effects of cannabis exposure on sperm, and their heritability.

Tadeusz Pacholczyk, a Yale Universitytrained Ph.D. neuroscientist and Catholic priest, is director of education at the National Catholic Bioethics Center in Philadelphia. He also spent 5 years studying theology and bioethics in Rome, “examining delayed ensoulment of the human embryo.” He told one Catholic group in 2006 that human embryonic stem cell research and cloning “represent the worst kind of medical research possible, where the powerful exploit the weak and vulnerable.” He has testified before state legislatures and been widely quoted in the press.

David A. Prentice, a Ph.D. biochemist, is vice president and research director at the Charlotte Lozier Institute. Prentice has followed the policy debate around fetal tissue use in research perhaps more closely than any abortion opponent, including testifying before Congress last year in opposition to U.S. funding of the research. Currently, he is urging the U.S. government to provide alternatives to two leading coronavirus vaccine candidates that are made using historical human fetal cell lines and have major U.S. funding behind them.

Kathleen Marie Schmainda is a biophysicist at the Medical College of Wisconsin and an opponent of human fetal tissue research. “Simply because something can be done does not mean that it should be permitted,” she wrote in an op-ed in USA Today.

Ingrid Skop, an obstetrician-gynecologist in private practice in San Antonio, Texas, is also a board member of the American Association of Pro-Life Obstetricians and Gynecologists and an associate member of the Charlotte Lozier Institute. She has testified before the Texas legislature in favor of abortion restrictions.

H. Joseph Yost, a developmental geneticist at the University of Utah School of Medicine, studies how cells are assigned identities in vertebrate embryos.